Evidence map›Paper›PMID 33171015›Full record

ArticleMicrobial biotechnology2021

Channelling carbon flux through the meta-cleavage route for improved poly(3-hydroxyalkanoate) production from benzoate and lignin-based aromatics in Pseudomonas putida H.

José Manuel Borrero-de Acuña, Izabook Gutierrez-Urrutia, Cristian Hidalgo-Dumont, Carla Aravena-Carrasco, Matias Orellana-Saez, Nestor Palominos-Gonzalez, Jozef B J H van Duuren, Viktoria Wagner, Lars Gläser, Judith Becker and 4 more

Open access · goldAbstract read
In one paragraph

Article in Microbial biotechnology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.9field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 31 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Metabolic engineering ofMetabolic engineering communications · 2022
    Article
  5. Article
  6. Fed-BatchFrontiers in bioengineering and biotechnology · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 3 institutions in 2 countries.

José Manuel Borrero-de AcuñaBiosystems Engineering Laboratory, Center for Bioinformatics and Integrative Biology (CBIB), Faculty of Life Sciences, Universidad Andres Bello, Santiago, Chile.
Izabook Gutierrez-UrrutiaBiosystems Engineering Laboratory, Center for Bioinformatics and Integrative Biology (CBIB), Faculty of Life Sciences, Universidad Andres Bello, Santiago, Chile.
Cristian Hidalgo-DumontBiosystems Engineering Laboratory, Center for Bioinformatics and Integrative Biology (CBIB), Faculty of Life Sciences, Universidad Andres Bello, Santiago, Chile.
Carla Aravena-CarrascoBiosystems Engineering Laboratory, Center for Bioinformatics and Integrative Biology (CBIB), Faculty of Life Sciences, Universidad Andres Bello, Santiago, Chile.
Matias Orellana-SaezBiosystems Engineering Laboratory, Center for Bioinformatics and Integrative Biology (CBIB), Faculty of Life Sciences, Universidad Andres Bello, Santiago, Chile.
Nestor Palominos-GonzalezBiosystems Engineering Laboratory, Center for Bioinformatics and Integrative Biology (CBIB), Faculty of Life Sciences, Universidad Andres Bello, Santiago, Chile.
Jozef B J H van DuurenInstitute of Systems Biotechnology, Saarland University, Saarbrücken, Germany.
Viktoria WagnerInstitute of Systems Biotechnology, Saarland University, Saarbrücken, Germany.
Lars GläserInstitute of Systems Biotechnology, Saarland University, Saarbrücken, Germany.
Judith BeckerInstitute of Systems Biotechnology, Saarland University, Saarbrücken, Germany.
Michael KohlstedtInstitute of Systems Biotechnology, Saarland University, Saarbrücken, Germany.
Flavia C ZacconiFacultad de Química y de Farmacia, Pontificia Universidad Católica de Chile, Santiago, Chile.
Christoph WittmannInstitute of Systems Biotechnology, Saarland University, Saarbrücken, Germany.
Ignacio Poblete-CastroBiosystems Engineering Laboratory, Center for Bioinformatics and Integrative Biology (CBIB), Faculty of Life Sciences, Universidad Andres Bello, Santiago, Chile.ORCID 0000-0001-6649-0389
Universidad Andrés Bello · CLSaarland University · DEPontificia Universidad Católica de Chile · CL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Lignin-based aromatics are attractive raw materials to derive medium-chain length poly(3-hydroxyalkanoates) (mcl-PHAs), biodegradable polymers of commercial value. So far, this conversion has exclusively used the ortho-cleavage route of Pseudomonas putida KT2440, which results in the secretion of toxic intermediates and limited performance. Pseudomonas putida H exhibits the ortho- and the meta-cleavage pathways where the latter appears promising because it stoichiometrically yields higher levels of acetyl-CoA. Here, we created a double-mutant H-ΔcatAΔA2 that utilizes the meta route exclusively and synthesized 30% more PHA on benzoate than the parental strain but suffered from catechol accumulation. The single deletion of the catA2 gene in the H strain provoked a slight attenuation on the enzymatic capacity of the ortho route (25%) and activation of the meta route by nearly 8-fold, producing twice as much mcl-PHAs compared to the wild type. Inline, the mutant H-ΔcatA2 showed a 2-fold increase in the intracellular malonyl-CoA abundance - the main precursor for mcl-PHAs synthesis. As inferred from flux simulation and enzyme activity assays, the superior performance of H-ΔcatA2 benefited from reduced flux through the TCA cycle and malic enzyme and diminished by-product formation. In a benzoate-based fed-batch, P. putida H-ΔcatA2 achieved a PHA titre of 6.1 g l

Indexed as

PolyhydroxyalkanoatesPseudomonas putidaBenzoatesCarbonCarbon CycleLigninBenzoatesCarbonLigninPolyhydroxyalkanoates

Identifiers

PMID33171015
PMCPMC8601166
OpenAlexW3104304150

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.